DUBLIN--(BUSINESS WIRE)--Mar. 7, 2017--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Barclays Global Healthcare Conference onTuesday, March 14, 2017 at 9:00 a.m. ET (1:00 p.m. GMT) from the Loews
Miami Beach Hotel in Miami, Fla. The presentation may be accessed under
the Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central nervous
system (CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates for
chronic diseases that include schizophrenia, depression, addiction and
multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more information, please visit Alkermes’ website
at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170307006026/en/
Source: Alkermes plc
Alkermes plc
Jennifer Zibuda, +1 781-609-6129
Corporate
Communications
